Transcendent Capital Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-292
Closed -$51.9K 89
2024
Q4
$51.9K Sell
292
-38
-12% -$6.75K 0.03% 183
2024
Q3
$65.2K Sell
330
-4
-1% -$790 0.03% 186
2024
Q2
$57.3K Buy
334
+4
+1% +$686 0.03% 176
2024
Q1
$60.1K Hold
330
0.03% 173
2023
Q4
$51.1K Buy
+330
New +$51.1K 0.03% 148